Improving patient outcomes through A.I. and data-driven cancer therapy recommendations for any patient anywhere
Perthera is a privately held corporation with an experienced international leadership and an advisory board that includes key thought leaders, researchers, and practitioners in artificial intelligence and precision medicine.
Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through our Perthera Report, which precisely matches cancer patients with multiple therapeutic options ranked by highest probability of best outcome.
With the Perthera Report:
- 73% of patients received more therapeutic options than provided by testing labs
- 75% of these additional therapeutic options were clinical trials